<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-113372" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Oropharyngeal Squamous Cell Carcinoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jamal</surname>
            <given-names>Zohaib</given-names>
          </name>
          <aff>Rawalpindi Medical University, Rawalpindi</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anjum</surname>
            <given-names>Fatima</given-names>
          </name>
          <aff>Temple University, Lewis Katz School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zohaib Jamal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatima Anjum declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-113372.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Oropharyngeal squamous cell carcinoma, commonly known as throat cancer or tonsil cancer, is a type of head and neck cancer that refers to the cancer of the base and posterior one-third of the tongue, the tonsils, soft palate, and posterior and lateral pharyngeal walls. The incidence of oropharyngeal squamous cell carcinoma is increasing in both old and young populations at an alarming level. This activity illustrates the evaluation and management of oropharyngeal squamous cell carcinoma and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the risk factors for developing oropharyngeal squamous cell carcinoma.</p></list-item><list-item><p>Describe the presentation of a patient with oropharyngeal squamous cell carcinoma.</p></list-item><list-item><p>Summarize management considerations for patients with oropharyngeal squamous cell carcinoma.</p></list-item><list-item><p>Outline the key differentials for the presentation of this condition and complications following treatments.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=113372&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=113372">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-113372.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Oropharyngeal squamous cell carcinoma (OPSCC), commonly known as throat cancer or tonsil cancer, refers to the cancer of the middle part of the pharynx, known as the oropharynx, which extends vertically from the soft palate to the superior area of the hyoid bone and includes the base and posterior one-third of the tongue, the tonsils, soft palate, and posterior and lateral pharyngeal walls.</p>
        <p>More than 90% of oropharyngeal cancers are squamous cell cancers, which are the cell lining of the oropharynx <xref ref-type="bibr" rid="article-113372.r1">[1]</xref>.</p>
        <p>Two types of oropharyngeal cancer can be distinguished: HPV-associated, due to an oral human papillomavirus infection, and non-HPV-associated, mainly due&#x000a0;to tobacco smoking and alcohol use.</p>
        <p>In addition to the direct invasion of the tissues, oropharyngeal cancer can spread through blood and lymphatics. The major symptoms of oropharyngeal cancer include sore throat, odynophagia, and dysphagia. Diagnosis is made based on biopsy results of the affected tissue. Treatment involves surgery, radiotherapy, chemotherapy, or a combination of these therapies.</p>
      </sec>
      <sec id="article-113372.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of oropharyngeal carcinoma is broadly categorized into HPV-associated and non-HPV-associated carcinomas.&#x000a0;</p>
        <p>HPV-associated oropharyngeal squamous cell carcinoma occurs in patients who have been infected with the human papillomavirus. Among the many types of human papillomavirus, HPV16 is the most common type found in oropharyngeal cancers <xref ref-type="bibr" rid="article-113372.r2">[2]</xref>.&#x000a0;</p>
        <p>Oral sex and open-mouthed kissing&#x000a0;are the most common reasons for oral HPV infection <xref ref-type="bibr" rid="article-113372.r3">[3]</xref>.</p>
        <p>On the other hand, smoking tobacco and alcohol consumption have been widely identified as the major risk factors for non-HPV-associated oropharyngeal carcinomas <xref ref-type="bibr" rid="article-113372.r4">[4]</xref>. Other less common risk factors include a diet low in vegetables and fruits, betel quid chewing,&#x000a0;poor nutrition, marijuana smoking, asbestos exposure, and certain genetic&#x000a0;mutations such as&#x000a0;P53 mutation and&#x000a0;CDKN2A (p16)&#x000a0;mutations <xref ref-type="bibr" rid="article-113372.r5">[5]</xref><xref ref-type="bibr" rid="article-113372.r6">[6]</xref><xref ref-type="bibr" rid="article-113372.r7">[7]</xref>.</p>
      </sec>
      <sec id="article-113372.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Oropharyngeal cancer is the&#x000a0;sixth most common cancer worldwide&#x000a0;<xref ref-type="bibr" rid="article-113372.r8">[8]</xref>.&#x000a0;HPV 16 is responsible for almost 90% of HPV-positive oropharyngeal cancers, and the prevalence is higher in males than females&#x000a0;<xref ref-type="bibr" rid="article-113372.r9">[9]</xref><xref ref-type="bibr" rid="article-113372.r10">[10]</xref>. The presence of HPV-associated OPSCC is much higher in the tonsils and base of the tongue. HPV-associated OPSCC tends to occur in a younger population&#x000a0;that smokes and drinks less; a higher percentage are males and report more oral sex partners&#x000a0;<xref ref-type="bibr" rid="article-113372.r11">[11]</xref>.</p>
      </sec>
      <sec id="article-113372.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In the case of HPV-associated OPSCC, the oral mucosa is exposed to the HPV infection, which persists and is not cleared. This persistence can lead to a precancerous lesion that may regress or not. If it does not, it will eventually progress to invasive OPSCC. Persistent HPV infections may progress to invasive cancer within ten years. However, the majority of these infections are cleared in one to two years <xref ref-type="bibr" rid="article-113372.r11">[11]</xref>.</p>
      </sec>
      <sec id="article-113372.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>In patients affected by oropharyngeal squamous cell carcinoma, the accumulation of genetic&#x000a0;changes results in&#x000a0;progression from mild and moderate dysplasia to severe dysplasia/carcinoma in situ. However,&#x000a0;in most HPV-positive oropharyngeal cancers, the tumor&#x000a0;originates deep&#x000a0;inside the tonsillar crypt epithelium.&#x000a0;This is why these cancers are neither visible on inspection nor noticeable by superficial brush biopsy&#x000a0;<xref ref-type="bibr" rid="article-113372.r12">[12]</xref>.</p>
      </sec>
      <sec id="article-113372.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with oropharyngeal cancer can present with a variety of symptoms depending on the location of the tumor. The most common presentations include persistent sore throat, dysphagia, odynophagia, dysarthria, presence of a lump in the neck, and otalgia. In addition, the patients may also complain of voice changes (hoarseness), unexplained weight loss, and hematemesis.</p>
        <p>Physical examination of the oropharynx may reveal either an ulcer or a red or white patch on the base&#x000a0;or posterior one-third of the tongue,&#x000a0;posterior and lateral pharyngeal walls, soft palate, or tonsils.</p>
      </sec>
      <sec id="article-113372.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A comprehensive protocol of investigations should be employed if there is a clinical suspicion of oropharyngeal cancer. These include:</p>
        <p>
<bold>Radiography</bold>
</p>
        <p>Plain radiography is done for dental assessment and bony invasion, but it is of limited value.</p>
        <p>
<bold>Ultrasonography</bold>
</p>
        <p>It is recommended to perform ultrasound with or without needle biopsy in all the patients reporting a neck lump because of its excellent accuracy of staging the nodal disease if employed by an experienced operator <xref ref-type="bibr" rid="article-113372.r13">[13]</xref>.</p>
        <p>
<bold>Magnetic Resonance Imaging (MRI)</bold>
</p>
        <p>MRI provides excellent visualization of the tumor infiltrating the soft tissue, is not distorted by the metallic dental restorations, and is considered optimal for the staging of the primary tumor <xref ref-type="bibr" rid="article-113372.r13">[13]</xref>.</p>
        <p>
<bold>Computed Tomography (CT)</bold>
</p>
        <p>A CT scan can not only be utilized to&#x000a0;estimate the size of the tumor&#x000a0;but also assist in&#x000a0;deciding on surgical removal of the tumor and&#x000a0;its spread to the lymph nodes in the neck or lower mandible.</p>
        <p>
<bold>Positron Emission Tomography (PET)</bold>
</p>
        <p>PET combined with CT-scan should be employed&#x000a0;in cases where conventional cross-sectional imaging fails to identify primary tumors <xref ref-type="bibr" rid="article-113372.r13">[13]</xref>.&#x000a0;PET scan is also employed&#x000a0;for the assessment and detection of the recurrence of the primary tumors <xref ref-type="bibr" rid="article-113372.r13">[13]</xref>.</p>
        <p>
<bold>Endoscopy and Laryngoscopy</bold>
</p>
        <p>Endoscopy and laryngoscopy&#x000a0;are performed after using an anesthetic spray or general anesthesia to visualize and examine the suspicious sites in detail and take the biopsy sample.</p>
        <p>
<bold>Biopsy</bold>
</p>
        <p>A biopsy of the suspicious area is performed to make a definitive diagnosis. The type of biopsy i.e., a fine-needle aspiration biopsy using a fine needle to collect a sample or oral brush biopsy, which is a newer, simpler, and more convenient method employing a small brush to collect the sample during routine dental examinations, depends upon the location of the cancer.</p>
        <p>
<bold>Human Papillomavirus Testing (HPV testing)</bold>
</p>
        <p>The American Society of Clinical Oncology recommends that HPV testing should be done on all newly diagnosed oropharyngeal cancers. This is done by polymerase chain reaction, which detects the HPV DNA.</p>
      </sec>
      <sec id="article-113372.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Surgery and radiotherapy are the two principle modalities used in the treatment of patients suffering from oropharyngeal cancers. Surgery or radiotherapy can be used primarily if&#x000a0;the tumor is small and has not advanced. However, if the disease has advanced or the tumor is larger, then a combination of surgery and radiotherapy is used. Implementing minimally invasive procedures, such as transoral laser microsurgery (TLM), as a first-line treatment modality for&#x000a0;oropharyngeal carcinomas have been found safe and efficacious <xref ref-type="bibr" rid="article-113372.r14">[14]</xref>.</p>
        <p>Other resection methods include&#x000a0;transoral robotic surgery, transoral video laryngoscopic surgery, transoral ultrasound surgery, and endoscopic laryngopharyngeal surgery <xref ref-type="bibr" rid="article-113372.r15">[15]</xref>.</p>
        <p>Following surgery, survival is increased in patients undergoing induction chemotherapy or concomitant chemoradiotherapy. In the case of unresectable tumors,&#x000a0;concomitant cisplatin-based chemotherapy, along with radiotherapy, is considered the gold standard and has shown to be better in terms of improving survival as compared to radiotherapy alone <xref ref-type="bibr" rid="article-113372.r16">[16]</xref>.&#x000a0;However, some studies have shown a parallel prognostic profile of concomitant use of carboplatin/paclitaxel in stage&#x000a0;III and IV non-metastatic oropharyngeal carcinomas but with fewer adverse effects <xref ref-type="bibr" rid="article-113372.r17">[17]</xref>.</p>
      </sec>
      <sec id="article-113372.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The conditions with presentations similar to oropharyngeal squamous cell carcinoma and which need to be excluded include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Actinic keratosis</p>
          </list-item>
          <list-item>
            <p>Erythroplasia</p>
          </list-item>
          <list-item>
            <p>Lichen planus</p>
          </list-item>
          <list-item>
            <p>Leukoplakias</p>
          </list-item>
          <list-item>
            <p>Lichenoid lesions</p>
          </list-item>
          <list-item>
            <p>Oral candidiasis</p>
          </list-item>
          <list-item>
            <p>Tonsillitis</p>
          </list-item>
          <list-item>
            <p>Traumatic lesions</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-113372.s11" sec-type="Staging">
        <title>Staging</title>
        <p>The American Joint Committee&#x000a0;on Cancer (AJCC) has defined the staging of oropharyngeal cancer. This follows a TNM staging system where T&#x000a0;relates to&#x000a0;the extent of the primary tumor, N indicates the involvement of regional lymph nodes, and M specifies the distant metastasis. In their 8th edition of the staging manual, AJCC has modified the staging system being used for staging oropharyngeal cancer with the addition of depth of invasion (DOI) of the primary tumor as a modification to the T category and extranodal extension (ENE) to upstage node-positive&#x000a0;oropharyngeal squamous cell carcinoma&#x000a0;<xref ref-type="bibr" rid="article-113372.r18">[18]</xref>. The new version of classification is more complex than its previous one, but it is better in terms of&#x000a0;stratifying survival of oropharyngeal squamous cell carcinoma&#x000a0;patients by stage&#x000a0;<xref ref-type="bibr" rid="article-113372.r19">[19]</xref>.</p>
        <p>
<bold>Staging of&#x000a0;Human Papillomavirus-Associated (p16-Positive) Oropharyngeal Cancer</bold>
</p>
        <p>
<bold>Primary Tumor (T)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T0-Primary tumor cannot be assessed</p>
          </list-item>
          <list-item>
            <p>T1-Tumor&#x000a0;smaller than 2cm in greatest dimension</p>
          </list-item>
          <list-item>
            <p>T2-Tumor larger&#x000a0;than 2cm but smaller than 4cm&#x000a0;in greatest dimension</p>
          </list-item>
          <list-item>
            <p>T3-Tumor larger&#x000a0;than 4cm or extension to the lingual surface of epiglottis</p>
          </list-item>
          <list-item>
            <p>T4-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond</p>
          </list-item>
          <list-item>
            <p>T4a-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible</p>
          </list-item>
          <list-item>
            <p>T4b-Very advanced local disease; tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery</p>
          </list-item>
        </list>
        <p>
<bold>Regional Lymph Nodes (N)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>NX-Regional lymph nodes cannot be assessed</p>
          </list-item>
          <list-item>
            <p>pN0-No regional lymph node metastasis</p>
          </list-item>
          <list-item>
            <p>pN1-Metastasis in 4 or fewer lymph nodes</p>
          </list-item>
          <list-item>
            <p>pN2-Metastasis in more than four lymph nodes</p>
          </list-item>
        </list>
        <p>
<bold>Metastasis (M)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>M0-No distant metastasis</p>
          </list-item>
          <list-item>
            <p>M1-Distant metastasis</p>
          </list-item>
        </list>
        <p>
<bold>Clinical Prognostic Groups for HPV-Mediated (p16+) Oropharyngeal Cancer (cTNM):</bold>
</p>
        <p>
<bold>Stage I</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T0&#x02013;T2N0M0</p>
          </list-item>
          <list-item>
            <p>T0&#x02013;T2N1M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage II</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T0&#x02013;T2N2M0</p>
          </list-item>
          <list-item>
            <p>T3N0&#x02013;N2M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage III</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T0&#x02013;T3N3M0</p>
          </list-item>
          <list-item>
            <p>T4N0&#x02013;N3M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage IV</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Any T/Any N M1</p>
          </list-item>
        </list>
        <p>
<bold>Pathological Prognostic Groups for HPV-Mediated (p16+) Oropharyngeal Cancer (pTNM):</bold>
</p>
        <p>
<bold>Stage I</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T0&#x02013;T2N0M0</p>
          </list-item>
          <list-item>
            <p>T0&#x02013;T2N1M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage II</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T0&#x02013;T2N2M0</p>
          </list-item>
          <list-item>
            <p>T3&#x02013;T4N0M0</p>
          </list-item>
          <list-item>
            <p>T3&#x02013;T4N1M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage III</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T3&#x02013;T4N2M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage IV</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Any T/Any N M1</p>
          </list-item>
        </list>
        <p>
<bold>Non-Human Papillomavirus-Associated (p16-Negative) Oropharyngeal Cancer</bold>
</p>
        <p>
<bold>Primary tumor (T)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tx-Primary tumor cannot be assessed</p>
          </list-item>
          <list-item>
            <p>Tis-Carcinoma in situ</p>
          </list-item>
          <list-item>
            <p>T1-Tumor 2 cm or smaller in greatest dimension</p>
          </list-item>
          <list-item>
            <p>T2-Tumor larger than 2 cm but not larger than 4 cm in greatest dimension</p>
          </list-item>
          <list-item>
            <p>T3-Tumor larger than 4 cm in greatest dimension or extension to the lingual surface of epiglottis</p>
          </list-item>
          <list-item>
            <p>T4-Moderately advanced or very advanced local disease</p>
          </list-item>
          <list-item>
            <p>T4a-Moderately advanced local disease; tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible</p>
          </list-item>
          <list-item>
            <p>T4b-Very advanced local disease; tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery</p>
          </list-item>
        </list>
        <p>
<bold>Regional lymph nodes (N)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>N0-No regional lymph node metastasis</p>
          </list-item>
          <list-item>
            <p>N1-Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE-negative</p>
          </list-item>
          <list-item>
            <p>N2-Metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE-negative; or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative; or metastasis in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative</p>
          </list-item>
          <list-item>
            <p>N2a-Metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE-negative</p>
          </list-item>
          <list-item>
            <p>N2b-Metastasis in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative</p>
          </list-item>
          <list-item>
            <p>N2c-Metastasis in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE-negative</p>
          </list-item>
          <list-item>
            <p>N3-Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE-negative; or metastasis in any lymph node(s) and clinically overt ENE-positive</p>
          </list-item>
          <list-item>
            <p>N3a-Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE-negative</p>
          </list-item>
          <list-item>
            <p>N3b-Metastasis in any node(s) and clinically overt ENE-positive</p>
          </list-item>
        </list>
        <p>
<bold>Metastasis&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>M0-No distant metastasis</p>
          </list-item>
          <list-item>
            <p>M1-Distant metastasis</p>
          </list-item>
        </list>
        <p>
<bold>Prognostic Stage Groups for&#x000a0;Clinical&#x000a0;and&#x000a0;Pathologic&#x000a0;Non&#x02013;HPV-Mediated (p16 -) Oropharyngeal Cancer</bold>
</p>
        <p>
<bold>Stage&#x000a0;0</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>TisN0M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage I</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T1N0M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage II</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T2N0M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage III</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T3N0M0</p>
          </list-item>
          <list-item>
            <p>T1N1M0</p>
          </list-item>
          <list-item>
            <p>T2N1M0</p>
          </list-item>
          <list-item>
            <p>T3N1M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage IVA</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>T4aN0M0</p>
          </list-item>
          <list-item>
            <p>T4aN1M0</p>
          </list-item>
          <list-item>
            <p>T1N2M0</p>
          </list-item>
          <list-item>
            <p>T2N2M0</p>
          </list-item>
          <list-item>
            <p>T3N2M0</p>
          </list-item>
          <list-item>
            <p>T4aN2M0</p>
          </list-item>
        </list>
        <p>
<bold>Stage IVB</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>AnyTN3M0</p>
          </list-item>
          <list-item>
            <p>T4bAnyNM0</p>
          </list-item>
        </list>
        <p>
<bold>Stage IVC</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>AnyTAnyNM1</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-113372.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The overall five-year survival rate in oropharyngeal carcinoma is around 60%. However, the prognosis varies&#x000a0;depending on the etiology. In comparison to HPV-negative oropharyngeal squamous cell carcinoma, HPV-positive oropharyngeal carcinoma shows a better prognosis and increased response to the treatment.<xref ref-type="bibr" rid="article-113372.r20">[20]</xref>&#x000a0;The higher survival with HPV-associated cancer is&#x000a0;because of favorable tumor biology and a healthier and&#x000a0;younger patient population.</p>
      </sec>
      <sec id="article-113372.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Treatment modalities employed in oropharyngeal cancers can result in several complications, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Oral mucositis</p>
          </list-item>
          <list-item>
            <p>Tissue fibrosis</p>
          </list-item>
          <list-item>
            <p>Hyposalivation</p>
          </list-item>
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Osteoradionecrosis</p>
          </list-item>
          <list-item>
            <p>Morbidity from jaw resection, disfigurement, and loss of function can&#x000a0;further&#x000a0;reduce&#x000a0;quality of life.<xref ref-type="bibr" rid="article-113372.r21">[21]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-113372.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Regarding primary prevention of HPV-related OPSCC, HPV vaccines are more than 90% effective in preventing vaccine-type HPV infections and their&#x000a0;correlated&#x000a0;anogenital precancerous lesions. Pinto et al. demonstrated that vaccination induces HPV antibody levels in the oral cavity that correlate with circulating levels <xref ref-type="bibr" rid="article-113372.r11">[11]</xref>. A screening tool useful in the early detection of HPV-DNA in oral rinses is promising, but very little data is available <xref ref-type="bibr" rid="article-113372.r11">[11]</xref>.</p>
        <p>Safe oral sex habits should be advised.&#x000a0;Educating the patients on the risks of betel quid chewing, alcohol use, and tobacco&#x000a0;smoking is of prime importance in controlling and preventing oropharyngeal cancers.</p>
      </sec>
      <sec id="article-113372.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>New and remarkable achievements have been developed regarding the strategies employed in oropharyngeal cancer diagnosis and treatment. These include the use of LASER-based technology to detect oropharyngeal squamous cell carcinoma at the early stages, especially in limited-resource settings, and&#x000a0;targeted therapy, which detects the mutations in genes that result in cancer and correct them, either inhibiting the growth of the tumor, its metastasis or target vascularity, cell signaling or transduction pathways&#x000a0;<xref ref-type="bibr" rid="article-113372.r22">[22]</xref>.</p>
        <p>In addition, the Food and Drug Administration (FDA) has approved vaccination against HPV to prevent HPV-related infections, reducing the incidence of oropharyngeal cancers.</p>
      </sec>
      <sec id="article-113372.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team consisting of an oncologist, psychotherapist, dentist, dietitian, histopathologist, surgeon, radiation oncologist, otorhinolaryngologist, clinical speech pathologist, a dental hygienist, and a chemotherapy nurse should work in collaboration to arrive at the best possible outcomes regarding the diagnosis and management of such patients <xref ref-type="bibr" rid="article-113372.r23">[23]</xref>.</p>
        <p>These professionals are also in an&#x000a0;optimal position to influence and advise patients on quitting smoking&#x000a0;and limiting alcohol in addition to maintaining healthy lifestyle habits such as eating fruits and vegetables,&#x000a0;observing dental hygiene, and having safe sex, which may contribute to preventing the increasing incidence of oropharyngeal squamous cell carcinoma.</p>
      </sec>
      <sec id="article-113372.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=113372&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=113372">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/oral-health/oropharyngeal-squamous-cell-carcinoma-throat-cancer-tonsil-cancer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=113372">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/113372/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=113372">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-113372.s18">
        <title>References</title>
        <ref id="article-113372.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shibahara</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Oral cancer -diagnosis and therapy-.].</article-title>
            <source>Clin Calcium</source>
            <year>2017</year>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>1427</fpage>
            <page-range>1427-1433</page-range>
            <pub-id pub-id-type="pmid">28947694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Isayeva</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Maswahu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brandwein-Gensler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review.</article-title>
            <source>Head Neck Pathol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>6 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S104</fpage>
            <page-range>S104-20</page-range>
            <pub-id pub-id-type="pmid">22782230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mair</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature.</article-title>
            <source>Postgrad Med J</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>1105</issue>
            <fpage>704</fpage>
            <page-range>704-709</page-range>
            <pub-id pub-id-type="pmid">28778951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bar&#x000f3;n</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Talamini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>La Vecchia</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>1993</year>
            <season>Nov-Dec</season>
            <volume>2</volume>
            <issue>6</issue>
            <fpage>519</fpage>
            <page-range>519-23</page-range>
            <pub-id pub-id-type="pmid">8268767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mizukawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Swe Swe Win</surname>
              </name>
              <name>
                <surname>Zaw Moe Thein</surname>
              </name>
              <name>
                <surname>Moe Thida Htwe</surname>
              </name>
              <name>
                <surname>Yoshioka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kimata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Myo Khin</surname>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Than Sein</surname>
              </name>
            </person-group>
            <article-title>The Incidence of Oral and Oropharyngeal Cancers in Betel Quid-Chewing Populations in South Myanmar Rural Areas.</article-title>
            <source>Acta Med Okayama</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>519</fpage>
            <page-range>519-524</page-range>
            <pub-id pub-id-type="pmid">29276225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Helgadottir</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>H&#x000f6;iom</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>J&#x000f6;nsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tuominen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ingvar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Olsson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.</article-title>
            <source>J Med Genet</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>51</volume>
            <issue>8</issue>
            <fpage>545</fpage>
            <page-range>545-52</page-range>
            <pub-id pub-id-type="pmid">24935963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marks</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Straif</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Berthiller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wyss</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brennan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Olshan</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Sturgis</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>ZF</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Muscat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lazarus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McClean</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vaughan</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Wunsch-Filho</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Curado</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Koifman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daudt</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Posner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boffetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Hashibe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>160</fpage>
            <page-range>160-71</page-range>
            <pub-id pub-id-type="pmid">24351902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chimenos-K&#x000fc;stner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marques-Soares</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Schemel-Su&#x000e1;rez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Aetiopathology and prevention of oropharyngeal cancer].</article-title>
            <source>Semergen</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>45</volume>
            <issue>7</issue>
            <fpage>497</fpage>
            <page-range>497-503</page-range>
            <pub-id pub-id-type="pmid">31079896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillison</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Capone</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Spafford</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Westra</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zahurak</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Viglione</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Symer</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Sidransky</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>2000</year>
            <month>May</month>
            <day>03</day>
            <volume>92</volume>
            <issue>9</issue>
            <fpage>709</fpage>
            <page-range>709-20</page-range>
            <pub-id pub-id-type="pmid">10793107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yete</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Saranath</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications.</article-title>
            <source>Oncology</source>
            <year>2018</year>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>133</fpage>
            <page-range>133-141</page-range>
            <pub-id pub-id-type="pmid">29241220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taberna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pav&#x000f3;n</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Alemany</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gillison</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Mes&#x000ed;a</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Human papillomavirus-related oropharyngeal cancer.</article-title>
            <source>Ann Oncol</source>
            <year>2017</year>
            <month>Oct</month>
            <day>01</day>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>2386</fpage>
            <page-range>2386-2398</page-range>
            <pub-id pub-id-type="pmid">28633362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pickard</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Broutian</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gillison</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years.</article-title>
            <source>Sex Transm Dis</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>559</fpage>
            <page-range>559-66</page-range>
            <pub-id pub-id-type="pmid">22706220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis-Jones</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Colley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.</article-title>
            <source>J Laryngol Otol</source>
            <year>2016</year>
            <month>May</month>
            <volume>130</volume>
            <issue>S2</issue>
            <fpage>S28</fpage>
            <page-range>S28-S31</page-range>
            <pub-id pub-id-type="pmid">27841111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melong</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Rigby</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Bullock</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Trites</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Transoral laser microsurgery for the treatment of oropharyngeal cancer: the Dalhousie University experience.</article-title>
            <source>J Otolaryngol Head Neck Surg</source>
            <year>2015</year>
            <month>Sep</month>
            <day>30</day>
            <volume>44</volume>
            <fpage>39</fpage>
            <pub-id pub-id-type="pmid">26419647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tirelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boscolo Nata</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Piovesana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quatela</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gardenal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hayden</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Transoral surgery (TOS) in oropharyngeal cancer: Different tools, a single mini-invasive philosophy.</article-title>
            <source>Surg Oncol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>643</fpage>
            <page-range>643-649</page-range>
            <pub-id pub-id-type="pmid">30449487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furness</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Glenny</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Worthington</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Pavitt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Clarkson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Macluskey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Conway</surname>
                <given-names>DI</given-names>
              </name>
              <collab>CSROC Expert Panel</collab>
            </person-group>
            <article-title>Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2010</year>
            <month>Sep</month>
            <day>08</day>
            <issue>9</issue>
            <fpage>CD006386</fpage>
            <pub-id pub-id-type="pmid">20824847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roskies</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kay-Rivest</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mascarella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sultanem</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mlynarek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hier</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.</article-title>
            <source>J Otolaryngol Head Neck Surg</source>
            <year>2016</year>
            <month>Oct</month>
            <day>10</day>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <pub-id pub-id-type="pmid">27724969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lydiatt</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brandwein</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ridge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Migliacci</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Loomis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-137</page-range>
            <pub-id pub-id-type="pmid">28128848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moeckelmann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ebrahimi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tou</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Ashford</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ch'ng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Palme</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma.</article-title>
            <source>Oral Oncol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>85</volume>
            <fpage>82</fpage>
            <page-range>82-86</page-range>
            <pub-id pub-id-type="pmid">30220324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Faraji</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fakhry</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.</article-title>
            <source>Cancer Metastasis Rev</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>449</fpage>
            <page-range>449-461</page-range>
            <pub-id pub-id-type="pmid">28812214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mupparapu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akintoye</surname>
                <given-names>SO</given-names>
              </name>
            </person-group>
            <article-title>Review of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner.</article-title>
            <source>Quintessence Int</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-79</page-range>
            <pub-id pub-id-type="pmid">23444208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balaji</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Oral squamous cell carcinoma: Advances in management.</article-title>
            <source>Indian J Dent Res</source>
            <year>2015</year>
            <season>Nov-Dec</season>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>559</fpage>
            <pub-id pub-id-type="pmid">26888230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-113372.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fried</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Confronting human papilloma virus/oropharyngeal cancer: a model for interprofessional collaboration.</article-title>
            <source>J Evid Based Dent Pract</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>14 Suppl</volume>
            <fpage>136</fpage>
            <page-range>136-46.e1</page-range>
            <pub-id pub-id-type="pmid">24929598</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
